View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

GoodRx, Inc.: Update to credit analysis following refinancing

Our credit view of this issuer reflects its moderate financial leverage on a gross basis, constrained by its high dependence on PBM operating model.

Moody's Ratings affirms GoodRx's B1 CFR, assigns B1 rating to proposed...

Moody's Ratings (Moody's) affirmed the ratings of GoodRx, Inc. ("GoodRx"), including its B1 Corporate Family Rating ("CFR"), B1-PD Probability of Default Rating ("PDR"), and B1 rating on the backed senior secured first lien revolving credit facility. Concurrently, Moody's assigned a B1 rating to Goo...

GoodRx, Inc.: Update to credit analysis following refinancing of capit...

Our credit view of this issuer reflects its moderate financial leverage on a gross basis, constrained by its high dependence on PBM operating model.

Moody's affirms GoodRx's B1 CFR, assigns B1 rating to new bank credit ...

Moody's Investors Service (Moody's) affirmed the ratings of GoodRx, Inc. ("GoodRx"), including the B1 Corporate Family Rating (CFR) and B1-PD Probability of Default Rating (PDR). Concurrently, Moody's assigned a B1 rating to the new 7-year backed senior secured first lien term loan B and to the newl...

GoodRx, Inc.: Update to credit analysis

Our credit view of this issuer reflects its moderate financial leverage on a gross basis, constrained by its high dependence on PBM operating model.

GoodRx, Inc.: Update to credit analysis

Our credit view of this issuer reflects its good revenue growth and moderate financial leverage, offset by its high dependence on the PBM business model.

Moody's announces completion of a periodic review of ratings of GoodRx...

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of GoodRx, Inc.. Global Credit Research- 15 Dec 2021. New York, December 15, 2021-- Moody's Investors Service has completed a periodic review of the ratings of GoodRx, Inc. and other ratings that are associated with the same analytical unit.

GoodRx, Inc.: Update to credit analysis

Our credit view of this issuer reflects its good profitability and moderate financial leverage, partially offset by business model is dependent on increasingly scrutinized PBMs .

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

GoodRx to Present Virtually at Upcoming Investor Conferences

GoodRx to Present Virtually at Upcoming Investor Conferences SANTA MONICA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced that executives from the Company will be presenting at the following virtual investor conferences: Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10, at 11:00 a.m. Pacific Time (2:00 p.m. Eastern Time)Citi 2021 Global Technology Virtual Conference on Tuesday, September 14, at 9:10 a.m. Pacific Time (12:10 p.m. Eastern Time)Goldman Sachs 30th Annual Communacopia...

 PRESS RELEASE

GoodRx Releases Second Quarter 2021 Financial Results

GoodRx Releases Second Quarter 2021 Financial Results SANTA MONICA, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: GDRX), America’s leading resource for healthcare savings, has released its second quarter 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at . GoodRx management will host a conference call and webcast today at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook. Today’s conference call and webcast will be extended to feature a presentation on pharm...

 PRESS RELEASE

CORRECTING and REPLACING - GoodRx and Boehringer Ingelheim Announce Jo...

CORRECTING and REPLACING - GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients Potential to provide approximately $15 million a year in savings for life-enhancing medications SANTA MONICA, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- In a release issued earlier today by GoodRx, Inc. (Nasdaq: GDRX), please note the announcement has been revised to include information about Synjardy®, Synjardy XR® and Stiolto Respimat®. Complete corrected text follows: , Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, and , a privately...

 PRESS RELEASE

GoodRx Announces Agreement with Surescripts to Provide Real-Time Drug ...

GoodRx Announces Agreement with Surescripts to Provide Real-Time Drug Discount Pricing in Electronic Health Records SANTA MONICA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: GDRX), America’s leading resource for healthcare savings, today announced that it has entered into an agreement with , the nation’s leading health information network, to deliver drug discount price information to prescribers using Surescripts Real-Time Prescription Benefit when prescribing medications for uninsured patients and patients whose price information isn’t already available from their PBM or health ...

 PRESS RELEASE

GoodRx Savings Increase Pharmacy Visits and Customer Loyalty For Retai...

GoodRx Savings Increase Pharmacy Visits and Customer Loyalty For Retailers A new consumer survey finds GoodRx discounts boost sales for retailers through new foot traffic SANTA MONICA, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- , Inc. (NASDAQ: GDRX), America’s leading resource for healthcare savings, today shared the results of a recent consumer survey showing the company’s impact on pharmacy retailers. Findings indicate that GoodRx helps pharmacies boost sales by driving in-store foot traffic, improving customer loyalty, and increasing medication affordability and access for their custo...

 PRESS RELEASE

GoodRx Announces Date for Second Quarter 2021 Earnings Release and Con...

GoodRx Announces Date for Second Quarter 2021 Earnings Release and Conference Call SANTA MONICA, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced it will release its second quarter 2021 financial results before U.S. markets open on Thursday, August 12, 2021. GoodRx management will hold a conference call and webcast that day at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook. Prior to the call, GoodRx will issue a press release containin...

Moody's announces completion of a periodic review of ratings of GoodRx...

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of GoodRx, Inc.. Global Credit Research- 04 Feb 2021. New York, February 04, 2021-- Moody's Investors Service has completed a periodic review of the ratings of GoodRx, Inc. and other ratings that are associated with the same analytical unit.

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch